CD274 and neoplasm: To explore the potential mechanism behind the enhanced anti-tumor activity of rPRV-iPD-L1 compared to rPRV-RFP, we immunostained PD-L1 as it has been reported that oncolytic virus treatment induces upregulation of PD-L1 in tumor cells.